Références
Amar L, Baudin E, Burnichon N, et al. (2007) Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J Clin Endocrinol Metab 92: 3822–3828
Gimenez-Roqueplo AP, Dahia PL, Robledo M (2012) An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Horm Metab Res 44: 328–333
Miettinen M, Wang ZF, Sarlomo-Rikala, et al. (2011) Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age. Am J Surg Pathol 35: 1712–1721
Référence
Freeman GA, Kimmelman J (2012) Publication and reporting conduct for pharmacodynamic analyses of tumor tissue in earlyphase oncology trials. Clin Cancer Res 18: 6478–6484
About this article
Cite this article
Brèves de l’AERIO. Oncologie 15, 202–205 (2013). https://doi.org/10.1007/s10269-013-2272-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10269-013-2272-z